MedCity News August 28, 2024
Marissa Plescia

To address the complicated healthcare landscape in the U.S., Pfizer launched a new direct-to-consumer virtual service called PfizerForAll. It follows Eli Lilly, which launched a similar product in January.

Biopharmaceutical company Pfizer is starting to serve consumers directly through its new telehealth platform called PfizerForAll, the company announced Tuesday. Pfizer declared that the platform is needed as consumers battle a confusing healthcare system.

PfizerForAll will support patients with conditions like migraines, Covid-19 or the flu. Through the platform, users can connect with independent healthcare professionals via telehealth or in person. They can also receive prescription medicines, over-the-counter treatments and diagnostic tests delivered to their home, or access them at their local pharmacy.

In addition, adult consumers can use the platform...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Technology, Telehealth
Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry
How Life Sciences Can Drive Innovation And Sustainability In Returns Management
10X Genomics at JPM: New Products, New Sales Team, New Markets
Enhancing Target Screening with CRISPR Libraries: Revolutionizing Drug Discovery and Functional Genomics
Daiichi Sankyo Announces New CEO

Share This Article